However, deletion of TP53 gene, which is associated with an aggressive course of the disease and poor prognosis along with a lack of response to treatment, is one of the alterations which may escape cytogenetic diagnoses in CLL. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.